Published in Medical Devices and Surgical Technology Week, August 27th, 2006
The agreement covers nanofiber based technologies and products in the professional and consumer wound care markets as well as other specialist medical related markets.
The JV will be the single point of contact for business development and license and supply agreements based on the relevant intellectual property and associated patents. The joint venture...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.